Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1595097Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
—
Net Income FY2025
$(79.0M)
EPS (Basic, as reported)
$-5.90
Net Margin FY2025
—
ROE FY2025
-53.2%
Total Equity
$148.0M
Shares Out
19M
Business description

Corbus Pharmaceuticals Holdings, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 2 → 0
Fiscal yearFY2016FY2017FY2018FY2019FY2020⚑FY2021⚑FY2022FY2023⚑FY2024FY2025
Revenue22536410———
Research & development(15)(26)(49)(90)(98)(36)(16)(31)(32)(70)
General & administrative(6)(9)(13)(24)(28)(20)(19)(14)(16)(15)
Total operating expenses(22)(35)(62)(113)(127)(57)(40)(45)(49)(85)
Operating income(20)(33)(57)(77)(123)(56)(40)(45)(49)(85)
Interest expense00—0(1)(3)(3)(4)(2)0
Interest & investment income——11——————
Other income (expense), net00161210(3)097
Income tax expense————————00
Net income(20)(32)(56)(71)(111)(46)(42)(45)(40)(79)
EPS — basic————($1.42)($0.37)($10.15)($10.31)($3.68)($5.90)
EPS — diluted——————($10.15)($10.31)($3.68)($5.90)
Shares outstanding — basic (M)————78123441113
Shares outstanding — diluted (M)—————4441113

Showing the latest 10 of 13 fiscal years.

  • ⚑ Weighted-average shares changed ×1.58 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷33.33 between FY2021 and FY2022 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.75 between FY2023 and FY2024 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.